Rob Etherington is the President and CEO of Clene – a clinical stage biopharmaceutical company. Clene’s goal is to create the first drug asset to improve neurological function and strives to create assets to help those with ALS, multiple sclerosis, and Parkinson’s Disease. Clene will know by the end of 2021 if their new asset can be used to treat all three of these diseases. Listen to learn more about this company and Rob’s various roles as the CEO of a biopharmaceutical company.
Brent Edmunds is the CEO of Stone Security – a commercial security integration company that specializes in video surveillance and card access control systems. Stone Security has focused on creating strong, loyal partnerships with its clients since its start in 2005, and each employee has learned ...
Edgar Carreon is the Founder and CEO of Dree – a peer-to-peer-laundry marketplace. For a monthly price, a Dree customer can have their laundry picked up and returned clean within 24 hours. Dree offers the perfect stay-at-home job for individuals looking to make a little income and who don’t mind ...
In this podcast, Isla Bragg, general manager of Slalom in Utah, talks about Slalom’s consulting work in Utah. Slalom opened its Utah office in January 2021 after noticing Utah’s rapid growth in population and business innovation. Slalom helps form strategies, create transformations, and fix techn...
